Tirz RxTirzepatide

Tirz Rx / Comparisons

Comparisons

Tirz Rx vs Mounjaro vs Zepbound: what actually differs
Mounjaro and Zepbound are the same FDA drug, tirzepatide, at different doses for different labels. Here's the real trial data, cost, and how compounded fits in.
Tirz Rx vs Ozempic: comparing tirzepatide and semaglutide
Tirzepatide vs semaglutide (Ozempic): SURPASS/SURMOUNT vs STEP trial data, weight loss %, dosing, side effects, and cost compared head-to-head.
Tirzepatide vs retatrutide: how the two GLP-1 drugs compare
Tirzepatide has FDA approval and phase 3 data showing up to 20.9% weight loss. Retatrutide is still in trials, with phase 2 results near 24%. Full comparison.
Tirzepatide vs semaglutide: what the trial data shows
Head-to-head trial data: tirzepatide averaged 15-21% weight loss vs semaglutide's 15%. Compare SURMOUNT, STEP, dosing, side effects, and cost.
Tirz Rx vs Wegovy: how tirzepatide stacks up
Wegovy averaged 15.2% weight loss at 68 weeks; tirzepatide hit 20.9% at 72 weeks (SURMOUNT-1). Full head-to-head on dosing, cost, and side effects.